News from us and our partners
Tags
Topics
0 results
Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca
Amolyt Pharma enters into definitive agreement to be acquired by AstraZeneca
Sensorion announces it has met primary endpoint for SENS-401 Phase 2a Clinical Study for residual hearing preservation
Signature of a partnership agreement with Kiro
AFYREN is ramping up its efforts to create a new path for organic waste recovery
Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system
Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases
Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development
Mainstay Medical announces US$125 million equity financing transaction
HighLife appoints Prof. Stephen Brecker Chief Medical Officer
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
NodThera publishes preclinical data demonstrating reversal of obesity and inflammation with clinical-stage brain-penetrant NLRP3 inflammasome inhibitors
deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale
Mainstay Medical announces receipt of FDA approval for MRI labeling on ReActiv8® Restorative Neurostimulation System
Sensorion announces a €50.5 million financing with participation from new and existing US and European healthcare specialist investors